ENTITY

Incyte Corp (INCY US)

67
Analysis
Health CareUnited States
Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.
more
bullishIncyte Corp
05 Dec 2024 18:00

The Takeover Buzz Around Incyte: What Makes It Irresistible to Big Pharma?

Incyte Pharmaceuticals has been the center of takeover speculation recently, with its stock rallying amid whispers of a potential...

Logo
542 Views
Share
bullishIncyte Corp
06 Nov 2024 08:00

Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off? - Major Drivers

Incyte exhibited a robust performance in its third quarter of 2024, marking a notable year of growth and advancement in its drug portfolio. Total...

Logo
198 Views
Share
bullishIncyte Corp
08 Aug 2024 07:00

Incyte Corporation: A Story Of Robust Pipeline Development and Strategic Acquisitions! - Major Drivers

Incyte Corporation reported its financial performance for the second quarter of 2024 with several notable highlights and strategic decisions that...

Logo
154 Views
Share
bullishIncyte Corp
11 May 2024 18:00

Incyte Corporation: Can It Capitalize On The Potential For Expansion Into Dermatology? - Major Drivers

Incyte Corp's first quarter 2024 earnings pointed towards the company's steady performance during the quarter and provided an update on its...

Logo
281 Views
Share
bullishIncyte Corp
23 Feb 2024 06:01

Incyte Corporation: Significant Clinical Progress in Pipeline Programs & Other Major Developments - Financial Forecasts

Incyte Corporation's 2023 earnings have been marked by the firm's strong performance following a 14% increase in product and royalty revenues...

Logo
374 Views
Share
x